A Fresh Look at Portillo's (PTLO) Valuation After Cut in Outlook and Guidance

If you are watching Portillo's (PTLO) lately, you are not alone. The company has been in the spotlight after reporting second-quarter results that failed to meet expectations and trimming both its quarterly and full-year outlook. Management pointed to softer overall performance and weaker-than-expected sales from new store locations, developments that are front and center for investors deciding whether to buy, hold, or move on from the stock now.

These numbers put fresh pressure on Portillo's shares, which slid 3.2% following the announcement. It’s been a tough stretch: over the past year, the stock has tumbled more than 52%, with momentum fading as lowered guidance overshadows recent leadership changes and ongoing expansion efforts. Even with annual revenue and income growth still positive, market sentiment has clearly shifted as expectations reset and risk perception rises.

With the bar now set lower for 2025, the big question is whether Portillo’s is becoming a bargain for value hunters, or if the market is simply catching up to slower growth realities. Is this the moment to buy the dip, or is further caution warranted?

Most Popular Narrative: 48.5% Undervalued

According to the most widely followed narrative, Portillo's is currently trading well below its estimated fair value. This suggests a substantial upside if its growth story plays out as expected.

“Portillo's has a substantial runway for geographic expansion beyond its core Midwest market, with a multi-format development pipeline (including new 2.0 prototypes and in-line/airport locations). This both increases its total addressable market and is projected to provide significant long-term unit growth, lifting total revenue and earnings potential as new markets mature and awareness builds.”

Want to know the expansion secrets behind this valuation? This narrative is driven by ambitious growth plans and bold financial projections that could redefine the company’s future. Curious about the earnings leap and revenue targets fueling such optimism? The full narrative reveals the surprising numbers powering this fair value estimate.

Result: Fair Value of $11.90 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, weakening new market sales and rising food and labor costs could quickly challenge this optimistic outlook, particularly if expansion does not lead to increased returns.

Find out about the key risks to this Portillo's narrative.

Another View: SWS DCF Model Signals Overvaluation

While analysts see potential upside, our DCF model tells a different story. This approach suggests Portillo’s shares are currently overvalued, which challenges the optimism around future growth. Which valuation do you trust more?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Portillo's for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Portillo's Narrative

If you have a different perspective or want to dive into the underlying figures, you can craft your own Portillo’s story in just a few minutes. Do it your way

A great starting point for your Portillo's research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Smart Investment Ideas?

Stop waiting on the sidelines. Amplify your portfolio’s potential by zeroing in on areas the market is buzzing about. These handpicked opportunities could set you apart from the crowd.

• Spot promising up-and-comers by targeting penny stocks with strong fundamentals using our powerful penny stocks with strong financials tool.
• Capture the next big wave in healthcare by tapping into companies on the cutting edge of medical AI advancements with healthcare AI stocks.
• Unlock overlooked bargains and seize stocks undervalued by their future cash flows through our tailored undervalued stocks based on cash flows screener.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com